Correction: ‘How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registrybased cohort study from Norway’
Unknown · 2024
Read Correction: ‘How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registrybased cohort study from Norway’ by Unknown (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11624793.txt.
Description
2024;14:e077027. doi:10.1136/ bmjopen-2023-077027 This article has been corrected since it was published online. The estimated weights in the last column of Table 2 were missing for most of the morbidities and erroneous for others. In addition, some of the morbidities labelled with footnotes had been labelled with the wrong footnote symbol.
Catalog record
| CREATOR | Unknown |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 5 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |